Hacettepe Kadın Hastalıkları Randevu

1: Ayhan A, Tunç M, Atasoy Karakaş L, Tekelioğlu T, Haberal Reyhan AN, Önalan G,

Kuşçu E. Oncologic and obstetric outcomes of early-stage epithelial ovarian

cancer patients who underwent fertility-sparing surgery: A retrospective study.

Int J Gynaecol Obstet. Feb doi: /ijgo Epub ahead of

print. PMID:

2: Cibula D, Akilli H, Jarkovsky J, van Lonkhuijzen L, Scambia G, Meydanli MM,

Ortiz DI, Falconer H, Abu-Rustum NR, Odetto D, Klát J, Dos Reis R, Zapardiel I,

Di Martino G, Presl J, Laky R, López A, Weinberger V, Obermair A, Pareja R,

Poncová R, Mom C, Bizzarri N, Bor?inová M, Aslan K, Salcedo Hernandez RA, Fons

G, Benešová K, Dostálek L, Ayhan A. Role of adjuvant therapy in intermediate-

risk cervical cancer patients - Subanalyses of the SCCAN study. Gynecol Oncol.

Mar; doi: /monash.pw Epub Jan PMID:

3: Bizzarri N, Dostálek L, van Lonkhuijzen LRCW, Giannarelli D, Lopez A,

Falconer H, Querleu D, Ayhan A, Kim SH, Ortiz DI, Klat J, Landoni F, Rodriguez

J, Manchanda R, Kos?un J, Ramirez PT, Meydanli MM, Odetto D, Laky R, Zapardiel

I, Weinberger V, Dos Reis R, Pedone Anchora L, Amaro K, Salehi S, Akilli H, Abu-

Rustum NR, Salcedo-Hernández RA, Jav?rková V, Mom CH, Scambia G, Cibula D.

Association of Hospital Surgical Volume With Survival in Early-Stage Cervical

Cancer Treated With Radical Hysterectomy. Obstet Gynecol. Jan

1;(1) doi: /AOG Epub Nov PMID:

4: Ok Atılgan A, Özen Ö, Haberal Reyhan AN, Ayhan A. Clinicopathologic Features

and the Loss of ARID1A Expression in Ovarian Seromucinous Borderline Tumors and

Seromucinous Carcinomas. Int J Surg Pathol. Nov doi:

/ Epub ahead of print. PMID:

5: Ayhan A, Akilli H, Abasiyanik MA, Taskiran C. Hyperthermic intraperitoneal

chemotherapy in the treatment of recurrent ovarian cancer: When, and for whom? J

Surg Oncol. Mar;(3) doi: /jso Epub Oct

PMID:

6: Yavas G, Kuscu UE, Ayhan A, Yavas C, Onal C. The utility of tesla MR-

guided adaptive stereotactic body radiotherapy for recurrent ovarian tumor -

Case reports and review of the literature. Int J Surg Case Rep.

Oct; doi: /monash.pw Epub Sep PMID:

; PMCID: PMC

7: Atilgan AO, Akcay EY, Ozen O, Haberal Reyhan AN, Ayhan A. Microsatellite

Instability Status and the Expression of p16 and Cyclin D1 Proteins in Uterine

Adenosarcoma and Their Clinicopathological Significance. Turk Patoloji Derg.

;39(1) English. doi: /tjpath PMID:

8: Ok Atılgan A, Yılmaz Akçay E, Özen Ö, Haberal Reyhan AN, Ayhan A. The

Overexpression of Programmed Death-Ligand 2 in Uterine Adenosarcoma: Correlation

with High-Grade Morphology, Mutant Type TP53 Expression and Clinical Outcomes.

Int J Surg Pathol. Apr doi:

/ Epub ahead of print. PMID:

9: Akgor U, Ayhan A, Shushkevich A, Ozdal B, Angelou K, Akbayır O, Kaidarova D,

Ulrikh E, Stepanyan A, Ortac F, Aliyev S, Ozgul N, Taranenka S, Haberal A,

Salman C, Seyhan A, Selcuk I, Haidopoulos D, Akıllı H, Bolatbekova R, Alaverdyan

A, Taskin S, Murshudova S, Batur M, Berlev I, Gultekin M. OPEC study: An

international multicenter study of ovarian preservation in endometrial cancers.

Int J Gynaecol Obstet. Nov;(2) doi: /ijgo Epub

Apr PMID:

Akilli H, Rahatli S, Aliyeva K, Altundag O, Kuscu UE, Ayhan A. Survival in

recurrent ovarian cancer patients before and after the bevacizumab era: an

observational single-centre study. J Obstet Gynaecol. Aug;42(6)

doi: / Epub Mar 9. PMID:

Taşdemir Ü, Ceran MU, Önder Dirican A, Akar S, Çelik Ç, Energin H, Görkemli

H, Mammadova N, Çolak E, Ayhan A. Incidence of unexpected leiomyosarcoma in a

Turkish province: a retrospective multi-centre study in a low income setting. J

Obstet Gynaecol. Aug;42(6) doi: /

Epub Mar 7. PMID:

Altın D, Taşkın S, Ortaç F, Tokgözoğlu N, Vatansever D, Güler AH, Güngör M,

Taşçı T, Beşe T, Turan H, Kahramanoğlu İ, Yalçın İ, Çelik Ç, Demirkıran F, Köse

F, Arvas M, Ayhan A, Taşkıran Ç. Diagnostic accuracy of sentinel node biopsy in

non-endometrioid, high-grade and/or deep myoinvasive endometrial cancer: A

Turkish gynecologic oncology group study (TRSGO-SLN). Gynecol Oncol.

Mar;(3) doi: /monash.pw Epub Jan PMID:

Cibula D, Dostálek L, Jarkovsky J, Mom CH, Lopez A, Falconer H, Scambia G,

Ayhan A, Kim SH, Isla Ortiz D, Klat J, Obermair A, Di Martino G, Pareja R,

Manchanda R, Kos?un J, Dos Reis R, Meydanli MM, Odetto D, Laky R, Zapardiel I,

Weinberger V, Benešová K, Bor?inová M, Cardenas F, Wallin E, Pedone Anchora L,

Akilli H, Abu-Rustum NR, Barquet-Muñoz SA, Jav?rková V, Fischerová D, van

Lonkhuijzen LRCW. Post-recurrence survival in patients with cervical cancer.

Gynecol Oncol. Feb;(2) doi: /monash.pw Epub

Dec PMID: ; PMCID: PMC

Vardar MA, Guzel AB, Taskin S, Gungor M, Ozgul N, Salman C, Kucukgoz-Gulec

U, Khatib G, Taskiran C, Dünder I, Ortac F, Yuce K, Terek C, Simsek T, Ozsaran

A, Onan A, Coban G, Topuz S, Demirkiran F, Takmaz O, Kose MF, Gocmen A,

Seydaoglu G, Gumurdulu D, Ayhan A. Could the Long-Term Oncological Safety of

Laparoscopic Surgery in Low-Risk Endometrial Cancer also Be Valid for the High-

Intermediate- and High-Risk Patients? A Multi-Center Turkish Gynecologic

Oncology Group Study Conducted with Endometrial Cancer Cases. (TRSGO-

End). Curr Oncol. Oct 29;28(6) doi:

/curroncol PMID: ; PMCID: PMC

Bulutay P, Haberal N, Özen Ö, Erdem Ö, Zeren EH, Kulac İ, Taskiran Ç,

Vatansever D, Ayhan A, Kapucuoğlu N. Reproducibility of Morphologic Parameters

of the International Endocervical Adenocarcinoma Criteria and Classification

System and Correlation With Clinicopathologic Parameters: A Multi-Institutional

Study. Int J Gynecol Pathol. Sep 1;41(5) doi:

/PGP Epub Dec 3. PMID:

Oz M, Meydanli MM, Altintas MI, Akilli H, Gultekin M, Ozgul N, Salman MC,

Taskin S, Yaprak E, Taskiran C, Vatansever D, Giray B, Yetkinel S, Celik H, Onan

MA, Ayhan A. The safety of major gynaecologic cancer surgery without routine

preoperative COVID testing in the COVID era: a multicentre, retrospective,

case-control study. J Obstet Gynaecol. Jul;42(5) doi:

/ Epub Oct PMID:

Cibula D, Dostálek L, Jarkovsky J, Mom CH, Lopez A, Falconer H, Fagotti A,

Ayhan A, Kim SH, Isla Ortiz D, Klat J, Obermair A, Landoni F, Rodriguez J,

Manchanda R, Kos?un J, Dos Reis R, Meydanli MM, Odetto D, Laky R, Zapardiel I,

Weinberger V, Benešová K, Bor?inová M, Pari D, Salehi S, Bizzarri N, Akilli H,

Abu-Rustum NR, Salcedo-Hernández RA, Jav?rková V, Sláma J, van Lonkhuijzen LRCW.

The annual recurrence risk model for tailored surveillance strategy in patients

with cervical cancer. Eur J Cancer. Oct 16; doi:

/monash.pw Epub ahead of print. PMID: ; PMCID:

PMC

Durmuş Y, Meydanlı MM, Akıllı H, Kayıkçıoğlu F, Güngördük K, Akbayır Ö,

Taşkın S, Çelik H, Ayhan A. Factors associated with the involvement of lymph

nodes in low-grade serous ovarian cancer. J Surg Oncol. Feb;(2)

doi: /jso Epub Oct 5. PMID:

Gungorduk K, Muallem J, Aşıcıoğlu O, Gülseren V, Güleç ÜK, Meydanlı MM,

Sehouli J, Özdemir A, Şahin H, Khatib G, Miranda A, Boran N, Şenol T, Yıldırım

N, Turan T, Oge T, Taşkın S, Vardar MA, Ayhan A, Muallem MZ. Survival outcomes

of women with grade 3 endometrioid endometrial cancer: the impact of adjuvant

treatment strategies. Arch Gynecol Obstet. Mar;(3) doi:

/s Epub Aug PMID:

Günakan E, Akıllı H, Kara AT, Altundağ Ö, Haberal AN, Meydanlı MM, Ayhan A.

Survival impact of number of removed para-aortic lymph nodes in stage I

epithelial ovarian cancer. Arch Gynecol Obstet. Feb;(2) doi:

/s Epub Aug PMID:

Sercan Ç, Haberal Reyhan AN, Özen Ö, Ayhan A. Clinicopathologic and

Prognostic Significance of CD47 Expression and Tumor-associated Macrophages in

Endometrial Carcinoma. Int J Gynecol Pathol. Jul 1;41(4) doi:

/PGP Epub Jul PMID:

Akilli H, Gunakan E, Haberal A, Altundag O, Kuscu UE, Taskiran C, Ayhan A.

Complications of cytoreductive surgery plus hyperthermic intraperitoneal

chemotherapy: An evaluation of cases. Int J Gynaecol Obstet.

Mar;(3) doi: /ijgo Epub Jun PMID:

Taşkın S, Varlı B, Altın D, Takmaz Ö, Vatansever D, Ersöz CC, Turan H,

Bulutay P, Zeren H, Havare SB, Karabük E, Naki M, Güngör M, Köse F, Ortaç F,

Arvas M, Ayhan A, Taşkıran Ç. Comparison of two intraoperative examination

methods for the diagnosis of sentinel lymph node metastasis in clinically early

stage endometrial cancer: A Turkish Gynecologic Oncology Group Study (TRSGO-

SLN). Eur J Obstet Gynecol Reprod Biol. Jun; doi:

/monash.pw Epub Apr PMID:

Ayhan A, Yilmaz Baran S, Vatansever D, Dogan Durdag G, Akilli H, Celik H,

Taskiran C. Feasibility of hyperthermic intraperitoneal chemotherapy (HIPEC) in

ovarian cancer during COVID pandemic. Int J Gynecol Cancer.

Jun;31(6) doi: /ijgc Epub Apr PMID:

; PMCID: PMC

Aslan K, Haberal A, Akıllı H, Meydanli MM, Ayhan A. Prognostic value of the

number of the metastatic lymph nodes in locally early-stage cervical cancer:

squamous cell carcinoma versus non-squamous cell carcinoma. Arch Gynecol Obstet.

Nov;(5) doi: /sw. Epub Mar

PMID:

Ayhan A, Gungorduk K, Khatib G, Fırat Cüylan Z, Boran N, Gökçü M, Çelik H,

Özgül N, Akbayir Ö, Şimşek T, Bakay A, Faruk Köse M, Tunç M, Küçükgöz Güleç Ü,

Koç S, Kuşçu E, Vardar MA, Akilli H, Taskiran C, Mutlu Meydanlı M. Prognostic

factors and survival outcomes of women with uterine leiomyosarcoma: A Turkish

Uterine Sarcoma Group Study Curr Probl Cancer. Oct;45(5) doi:

/monash.pwoblcancer Epub Feb 9. PMID:

Vatansever D, Taskiran C, Mutlu Meydanli M, Gungorduk K, Akbayir O, Yalcin

I, Demirkiran F, Sozen H, Ozgul N, Celik H, Onan MA, Taskin S, Oge T, Simsek T,

Abboud S, Yuksel IT, Ayhan A. Impact of cytoreductive surgery on survival of

patients with low-grade serous ovarian carcinoma: A multicentric study of

Turkish Society of Gynecologic Oncology (TRSGO-OvCa). J Surg Oncol.

May;(8) doi: /jso Epub Mar 3. PMID:

Akıllı H, Tohma YA, Günakan E, Küçükyıldız İ, Tunç M, Haberal Reyhan N,

Ayhan A. Factors affecting parametrial involvement in cervical cancer patients

with tumor size ≤4 cm and selection of low-risk patient group. J Turk Ger

Gynecol Assoc. Feb 24;22(1) doi:

/monash.pws Epub Jan PMID: ; PMCID:

PMC

Cuylan ZF, Akilli H, Gungorduk K, Demirkiran F, Oz M, Salman MC, Sozen H,

Celik H, Gokcu M, Bese T, Meydanli MM, Ozgul N, Topuz S, Kuscu E, Kuru O, Gokmen

S, Gultekin M, Ayhan A. Is the extent of lymphadenectomy a prognostic factor in

International Federation of Gynecology and Obstetrics stage II endometrioid

endometrial cancer? J Obstet Gynaecol Res. Mar;47(3) doi:

/jog Epub Jan PMID:

Ayhan A, Tunc M, Boran N, Khatib G, Gokcu M, Simsek T, Ozen OI, Toptas T,

Yalcin I, Meydanli MM. High-grade endometrial stromal sarcoma versus

undifferentiated uterine sarcoma: a Turkish uterine sarcoma group study

Arch Gynecol Obstet. Aug;(2) doi: /s

Epub Jan 3. PMID:

Ayhan A, Toptas T, Oz M, Vardar MA, Kayikcioglu F, Ozgul N, Gokcu M, Simsek

T, Tunc M, Meydanli MM. Low-grade endometrial stromal sarcoma: A Turkish uterine

sarcoma group study analyzing prognostic factors and disease outcomes. Gynecol

Oncol. Mar;(3) doi: /monash.pw Epub Dec

PMID:

Altin D, Taskin S, Tokgozoglu N, Vatansever D, Guler AH, Gungor M, Tasci T,

Turan H, Kahramanoglu I, Yalcin I, Celik C, Kose F, Ortac F, Arvas M, Ayhan A,

Taskiran C. Can risk groups accurately predict non-sentinel lymph node

metastasis in sentinel lymph node-positive endometrial cancer patients? A

Turkish Gynecologic Oncology Group Study (TRSGO-SLN). J Surg Oncol.

Feb;(2) doi: /jso Epub Dec 1. PMID:

Güngördük K, Plett H, Gülseren V, Meydanlı M, Boyraz G, Özdemir İ, Şahin H,

Şenol T, Yıldırım N, Turan T, Öge T, Gökçü M, Taşkın S, Ayhan A, Ataseven B. Is

the Oncological Outcome of Early Stage Uterine Carcinosarcoma Different from

That of Grade 3 Endometrioid Adenocarcinoma? Oncol Res Treat.

;44() doi: / Epub Nov PMID:

Ayhan A, Oz M, Topfedaisi Ozkan N, Aslan K, Altintas MI, Akilli H, Demirtas

E, Celik O, Ülgü MM, Birinci S, Meydanli MM. Perioperative SARS-CoV-2 infection

among women undergoing major gynecologic cancer surgery in the COVID era: A

nationwide, cohort study from Turkey. Gynecol Oncol. Feb;(2)

doi: /monash.pw Epub Nov PMID: ; PMCID:

PMC

Gultekin M, Ak S, Ayhan A, Strojna A, Pletnev A, Fagotti A, Perrone AM,

Erzeneoglu BE, Temiz BE, Lemley B, Soyak B, Hughes C, Cibula D, Haidopoulos D,

Brennan D, Cola E, van der Steen-Banasik E, Urkmez E, Akilli H, Zapardiel I,

Tóth I, Sehouli J, Zalewski K, Bahremand K, Chiva L, Mirza MR, Papageorgiou M,

Zoltan N, Adámková P, Morice P, Garrido-Mallach S, Akgor U, Theodoulidis V, Arik

Z, Steffensen KD, Fotopoulou C. Perspectives, fears and expectations of patients

with gynaecological cancers during the COVID pandemic: A Pan-European study

of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe).

Cancer Med. Jan;10(1) doi: /cam Epub Nov

PMID: ; PMCID: PMC

Karakas LA, Atilgan AO, Akilli H, Kuscu UE, Haberal A, Ayhan A. Nulliparity

and postmenopausal status are independent factors of malignancy potential of

endometrial intraepithelial neoplasia in polyps. Int J Gynaecol Obstet.

Mar;(3) doi: /ijgo Epub Dec PMID:

Ayhan A, Akilli H. Prognostic factors associated with cytoreductive surgery

plus hyperthermic intraperitoneal chemotherapy in recurrent ovarian cancer. Int

J Gynaecol Obstet. Feb;(2) doi: /ijgo Epub

Oct PMID:

Kizilkan Y, Tohma YA, Senel S, Gunakan E, Oguzulgen AI, Aktas BK, Bulut S,

Gokkaya CS, Ozden C, Ozkardes H, Ayhan A. The Effects of Transobturator Tape

Surgery on Sexual Functions in Women With Stress Urinary Incontinence. Sex Med.

Dec;8(4) doi: /monash.pw Epub Sep 3. PMID:

; PMCID: PMC

Bhandoria GP, Bhandarkar P, Ahuja V, Maheshwari A, Sekhon RK, Gultekin M,

Ayhan A, Demirkiran F, Kahramanoglu I, Wan YL, Knapp P, Dobroch J, Zmaczy?ski A,

Jach R, Nelson G. Enhanced Recovery After Surgery (ERAS) in gynecologic

oncology: an international survey of peri-operative practice. Int J Gynecol

Cancer. Oct;30(10) doi: /ijgc Epub Aug

4. PMID:

Günakan E, Tohma YA, Karakaş LA, Akıllı H, Haberal AN, Ayhan A. Prognostic

impact of p16 and p53 gene expressions in stage 1a epithelial ovarian cancer.

Obstet Gynecol Sci. Jul;63(4) doi: /ogs Epub

Jun PMID: ; PMCID: PMC

Altin D, Taşkın S, Kahramanoglu I, Vatansever D, Tokgozoglu N, Karabük E,

Turan H, Takmaz Ö, Naki MM, Güngör M, Köse MF, Ortac F, Arvas M, Ayhan A,

Taskiran C. Combination of sentinel lymph node mapping and uterine frozen

section examination to reduce side-specific lymphadenectomy rate in endometrial

cancer: a Turkish Gynecologic Oncology Group study (TRSGO-SLN). Int J

Gynecol Cancer. Jul;30(7) doi: /ijgc Epub

May PMID:

Ayhan A, Tohma YA, Tunc M. Fertility preservation in early-stage endometrial

cancer and endometrial intraepithelial neoplasia: A single-center experience.

Taiwan J Obstet Gynecol. May;59(3) doi:

/monash.pw PMID:

Aslan K, Meydanli MM, Akilli H, Durmuş Y, Gökçü M, Kayıkçıoğlu F, Demirkiran

F, Ayhan A. Does lymph node ratio have any prognostic significance in maximally

cytoreduced node-positive low-grade serous ovarian carcinoma? Arch Gynecol

Obstet. Jul;(1) doi: /s Epub May

PMID:

Gultekin M, Guler OC, Yuce Sari S, Akkus Yildirim B, Onal C, Celik H, Yuce

K, Ayhan A, Arik Z, Kose F, Altundag O, Zoto Mustafayev T, Atalar B, Bolukbasi

Y, Yildiz F. Multi-institutional validation of the ESMO-ESGO-ESTRO consensus

conference risk grouping in Turkish endometrial cancer patients treated with

comprehensive surgical staging. J Obstet Gynaecol. Apr;41(3) doi:

/ Epub Apr PMID:

Dilaver E, Suzen M, Demir O, Iric S, Ayhan AO, Uckan S. Changes of Stress

Distributions Around Pterygomaxillary Junction With Different Osteotome

Angulations. J Craniofac Surg. Sep;31(6) doi:

/SCS PMID:

Akilli H, Tohma YA, Bulut AN, Karakas LA, Haberal AN, Kuscu UE, Ayhan A.

Comparison of no adjuvant treatment and radiotherapy in early-stage cervical

carcinoma with intermediate risk factors. Int J Gynaecol Obstet.

Jun;(3) doi: /ijgo Epub Apr PMID:

Günakan E, Tohma YA, Tunç M, Akıllı H, Şahin H, Ayhan A. Factors associated

with surgical morbidity of primary debulking in epithelial ovarian cancer.

Obstet Gynecol Sci. Jan;63(1) doi: /ogs Epub

Dec PMID: ; PMCID: PMC

Taşkın S, Altin D, Vatansever D, Tokgozoglu N, Karabük E, Turan H, Takmaz Ö,

Kahramanoglu I, Naki MM, Güngör M, Köse F, Ortac F, Arvas M, Ayhan A, Taskiran

C. Sentinel lymph node biopsy in early stage endometrial cancer: a Turkish

gynecologic oncology group study (TRSGO-SLN). Int J Gynecol Cancer.

Mar;30(3) doi: /ijgc Epub Dec PMID:

Aslan K, Meydanli MM, Oz M, Tohma YA, Haberal A, Ayhan A. The prognostic

value of lymph node ratio in stage IIIC cervical cancer patients triaged to

primary treatment by radical hysterectomy with systematic pelvic and para-aortic

lymphadenectomy. J Gynecol Oncol. Jan;31(1):e1. doi:

/jgoe1. Epub Jun PMID: ; PMCID: PMC

Yorgancı A, Meydanlı MM, Kadıoğlu N, Taşkın S, Kayıkçıoğlu F, Altın D,

Atasoy L, Haberal AN, Kınay T, Akgül MA, Tapısız ÖL, Evliyaoğlu Ö, Tekin ÖM,

Fırat Ortaç U, Ayhan A. Incidence and outcome of occult uterine sarcoma: A

multi-centre study of operations performed for presumed uterine leiomyoma.

J Gynecol Obstet Hum Reprod. Jan;49(1) doi:

/monash.pw Epub Sep 6. PMID:

Gurkan D, Ceren Akin A, Sahin H, Aytac Tohma Y, Sahin EA, Gunakan E,

Iflazoglu N, Nihan Haberal A, Ayhan A. Oncologic outcomes in patients undergoing

maximal or optimal cytoreductive surgery for Stage 3C serous ovarian, tubal or

peritoneal carcinomas. J Obstet Gynaecol. May;40(4) doi:

/ Epub Sep 4. PMID:

Kahramanoglu I, Meydanli MM, Taranenka S, Ayhan A, Salman C, Sanci M,

Demirkiran F, Ortac F, Haidopoulos D, Sukhin V, Kaidarova D, Stepanyan A,

Farazaneh F, Aliyev S, Ulrikh E, Kurdiani D, Yalcin İ, Mavrichev S, Akilli H,

Sarı ME, Pletnev A, Aslan K, Bese T, Kairbayev M, Vlachos D, Gultekin M. SATEN

III-Splitting Adjuvant Treatment of stage III ENdometrial cancers: an

international, multicenter study. Int J Gynecol Cancer.

Oct;29(8) doi: /ijgc Epub Sep 2. PMID:

Selcuk I, Meydanli MM, Yalcin I, Gungorduk K, Akgol S, Çelik H, Ayhan A.

Comparison of survival outcomes in optimally and maximally cytoreduced stage

IIIC ovarian high-grade serous carcinoma: Women with only peritoneal tumor

burden versus women with both peritoneal and lymphogenous dissemination. J

Obstet Gynaecol Res. Oct;45(10) doi: /jog Epub

Aug 1. PMID:

Ayhan A, Aslan K, Bulut AN, Akilli H, Öz M, Haberal A, Meydanli MM. Is the

revised FIGO staging system for cervical cancer more prognostic than the

FIGO staging system for women previously staged as IB disease? Eur J Obstet

Gynecol Reprod Biol. Sep; doi: /monash.pw

Epub Jul 6. PMID:

Ayhan A, Aslan K, Öz M, Tohma YA, Kuşçu E, Meydanli MM. Para-aortic lymph

node involvement revisited in the light of the revised FIGO staging system

for cervical cancer. Arch Gynecol Obstet. Sep;(3) doi:

/s Epub Jul 1. PMID:

Şahin H, Karatas F, Coban G, Özen Ö, Erdem Ö, Onan MA, Ayhan A. Uterine

smooth muscle tumor of uncertain malignant potential: fertility and clinical

outcomes. J Gynecol Oncol. Jul;30(4):e doi: /jgoe

Epub Feb 4. PMID: ; PMCID: PMC

Akilli H, Rahatli S, Tohma YA, Karakas LA, Altundag O, Ayhan A. Effect of

increased number of neoadjuvant chemotherapy cycles on tumor resectability and

pathologic response in advanced stage epithelial ovarian cancer. J BUON.

Dec;23(7) PMID:

Günakan E, Atan S, Haberal AN, Küçükyıldız İA, Gökçe E, Ayhan A. A novel

prediction method for lymph node involvement in endometrial cancer: machine

learning. Int J Gynecol Cancer. Feb;29(2) doi:

/ijgc Epub Dec PMID:

Ayhan A, Şahin H, Sari ME, Yalçin I, Haberal A, Meydanli MM. Prognostic

significance of lymphovascular space invasion in low-risk endometrial cancer.

Int J Gynecol Cancer. Mar;29(3) doi: /ijgc

Epub Jan PMID:

Sahin H, Meydanli MM, Sari ME, Kocaman E, Cuylan ZF, Yalcin I, Coban G, Özen

Ö, Sirvan L, Güngör T, Ayhan A. Recurrence patterns and prognostic factors in

lymphovascular space invasion-positive endometrioid endometrial cancer

surgically confined to the uterus. Taiwan J Obstet Gynecol.

Jan;58(1) doi: /monash.pw PMID:

Sarı ME, Meydanlı MM, Yalçın I, Şahin H, Çoban G, Çelik H, Kuşçu E, Gungor

TARİHÇE

Hacettepe Kadın Doğum Kliniği yılında Dr. Çetin Kaya Aydar başkanlığında; Dr. Kemal Üstay, Dr. Muammer Alpay, Dr. Mithat Erdoğan, Dr. Vacit Özberkmen, Dr. Ünal Ural Ve Dr. Eflatun Gökşin’den oluşan bir grup tarafından kuruldu. yılında Jinekolojik onkoloji konseyi oluşturularak üniter hizmete adım atıldı, üreme endokrinolojisi yılından beri aktif olarak jinekolojik endoskopi, tüp bebek, androloji ve menopoz üniteleri ile çalışmalarını sürdürmektedir. Maternal fetal tıp ünitesi de riskli gebelik, noninvazif ve invazif perinatal tanı üniteleri ile en çağdaş şekilde hizmet vermektedir.

YER VE KAPASİTE

Kadın hastalıkları ve Doğum Ana Bilim dalı polikliniğinde öğretim üyeleri ve araştırma görevlilerince poliklinik hizmeti verilmektedir. Poliklinik bünyesinde Aile planlaması ünitesi ve yüksek riskli gebelikler polikliniği de mevcuttur. Bölüm 83, 44 yatak ile jinekoloji servisi, Bölüm 82 36 yatak ile obstetrik servisi olarak hizmet vermektedir.

Bölüm 81 Doğumhane bünyesinde 11 yatak ve 2 doğum salonu mevcuttur. Bölüm 81’de 2 ameliyat salonu operatif doğumlar, endoskopik cerrahiler ve günlük cerrahiler için hizmettedir. A katı ameliyathanede de 5 numaralı ameliyat salonu kadın doğum ameliyatları için kullanılmaktadır.

ARAŞTIRMA GÖREVLİSİ EĞİTİM SÜRECİ

Tıpta uzmanlık sınavı (TUS) ile alınmaktadır. Her Eylül TUS döneminde 4 araştırma görevlisi alınmaktadır. Araştırma görevlilerinin eğitim süresi 5 yıldır.

Uzmanlık eğitimi süresince Anestezi, genel cerrahi, üroloji ve patoloji rotasyonları yapılmaktadır.

Ana bilim dalının araştırma görevlileri için eğitim programı yıllık olarak düzenlenmekte, öğretim üyeleri ve araştırma görevlilerine dağıtılmaktadır.

ANA BİLİM DALI ÇALIŞMA KONULARI

Ana bilim dalında her hafta Salı günleri eğitime ayrılmıştır. Salı günleri haftalık Jinekoloji, Obstetrik,Yüksek Riskli Gebelikler ve Poliklinik olguları sunulur ve tartışılır. Belirlenmiş seminerler ilgili öğretim üyeleri veya araştırma görevlilerince sunulur. Asistan eğitim programı çerçevesinde her Çarşamba günü arası belirlenmiş konularda sunu ve tartışma yapılır.

Üreme endokrinolojisi ve infertilite ünitesi (Cuma) ve jinekolojik onkoloji ünitesini (Perşembe) haftalık toplantıları mevcuttur.

Aylık morbidite-mortalite, jinekopatoloji ve doğum-neonatoloji toplantıları da gerçekleştirilmektedir.

Ana bilim dalı bünyesinde üreme endokrinolojisi ve İnfertilite ünitesi, Maternal fetal tıp ünitesi ve jinekolojik onkoloji ünitesi hizmet vermektedir.

Üreme endokrinolojisi ve İnfertilite ünitesi, Maternal fetal tıp ünitesi ve jinekolojik onkoloji ünitesi hem temel, hem de klinik tıp alanında pek çok çalışma yürütmektedir.